The ROE as of December 2024 (TTM) for 180 Life Sciences Corp. (ATNF) is -559.06%

According to 180 Life Sciences Corp.’s latest financial reports and current stock price. The company's current ROE is -559.06%. This represents a change of -313.48% compared to the average of 261.88% of the last 4 quarters.

180 Life Sciences Corp. (ATNF) Historical ROE (quarterly & annually)

How has ATNF ROE performed in the past?

The mean historical ROE of 180 Life Sciences Corp. over the last ten years is 2.19%. The current -559.06% ROE has changed -125.58% with respect to the historical average. Over the past ten years (40 quarters), ATNF's ROE was at its highest in in the September 2023 quarter at 6.87%. The ROE was at its lowest in in the June 2021 quarter at -863.68%.

180 Life Sciences Corp. (ATNF) ROE by Quarter and Year

Discovering the peaks and valleys of 180 Life Sciences Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

180 Life Sciences Corp. (ATNF) Average ROE

How has ATNF ROE performed in the past?

The current ROE of 180 Life Sciences Corp. (ATNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

180 Life Sciences Corp. (ATNF) ROE vs. Peers

How is ATNF’s ROE compared to its peers?

180 Life Sciences Corp.’s ROE is greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), less than Altamira Therapeutics Ltd. (783.37%), greater than Immix Biopharma, Inc. (-102.10%), greater than Enveric Biosciences, Inc. (-201.01%), greater than Palisade Bio, Inc. (-148.31%), less than CNS Pharmaceuticals, Inc. (695.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), less than Apexigen, Inc. (48.27%),

Build a custom stock screener for 180 Life Sciences Corp. (ATNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 180 Life Sciences Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

180 Life Sciences Corp. (ATNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like 180 Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.